Abstract Adult weight gain is positively associated with postmenopausal breast cancer and inversely associated with premenopausal breast cancer risk. To date, no metaanalysis has been conducted to assess this association by estrogen receptor (ER) and progesterone receptor (PR) status. We searched PubMed for relevant studies published through March 2010. Summarized risk estimates (REs) with 95% confidence intervals (CIs) were calculated using random effects or fixed effects models. We retrieved nine articles on weight gain from adulthood to reference age and ER-and/or PR-defined breast cancer risk, reporting on three prospective cohort studies and eight case-control studies. Comparing the highest versus the lowest categories of adult weight gain, risk was increased for ER ? PR ? and ER ? tumors combined (11 studies; RE = 2.03; 95% CI 1.62, 2.45). Statistically significant heterogeneity (p heterogeneity = 0.002) was shown between REs for a mixed population of pre-and postmenopausal women combined (4 studies; RE = 1.54; 95% CI 0.86, 2.22) and for postmenopausal women only (7 studies; RE = 2.33; 95% CI 2.05, 2.60). Risk for ER -PR -tumors among postmenopausal women was also slightly increased (7 studies; RE = 1.34; 95% CI 1.06, 1.63), but statistically significantly different from risk for ER ? PR ? tumors (p heterogeneity \ 0.0001). No associations were observed for ER ? PR
Introduction
Body weight is an established risk factor for postmenopausal breast cancer whereas it is inversely associated with premenopausal breast cancer risk [1] . This may be due to differential effects of obesity on circulating endogenous estrogen levels according to menopausal status [2] . In postmenopausal women, estrogen is mainly synthesized by adipose tissue. Fatter women have larger adipose stores than leaner women, resulting in higher circulating levels of estrogen and lower levels of sex hormone-binding globulin (SHBG). In premenopausal women, estrogens mainly originate from ovarian synthesis, and levels are much higher than after menopause. However, overweight or obese premenopausal women are more likely to have anovulatory cycles and a greater clearance rate of estrogens by the liver compared to normal weight women, resulting in lower levels of circulating estrogen and progesterone.
A recent meta-analysis has shown that the association between body mass index (BMI) and breast cancer risk is also heterogeneous according to estrogen receptor (ER) and progesterone receptor (PR) status [3] . Higher BMI was associated with higher risk for ER ? PR ? tumors in postmenopausal women but had a protective effect on ER ? PR [4] . BMI reflects both lean and fat mass whereas adult weight gain largely reflects an increase in body fat independent of BMI [4] . Several studies examining both adult weight gain and adult BMI in the same study population have found weight gain to be an equivalent [5, 6] or stronger [4, [7] [8] [9] [10] predictor of postmenopausal breast cancer risk than recent BMI. Adult weight gain has been inversely associated with premenopausal breast cancer risk [11] .
Ten studies have investigated the association between adult weight gain and breast cancer risk according to ER/PR status of the tumor [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] , and no systematic review or meta-analysis has been conducted thus far. Results of these studies were inconsistent; however, a limitation was that the number of non-ER ? PR ? tumors in individual studies was mostly small and comparisons for these groups were likely to be underpowered. Therefore, the aim of this meta-analysis was to investigate whether the association between adult weight gain and breast cancer risk differed according to ER/PR status of the tumor.
Materials and methods

Selection of studies
A systematic PubMed search was performed to identify epidemiologic studies published through March 2010 that reported on the association between adult weight gain and risk for breast cancer defined by ER/PR status. We used a combination of the Medical Subject Headings (i.e., breast neoplasms, body weight, BMI, ERs, PRs) and also searched for related keywords in title and abstract. The query retrieved 899 articles. In addition, cited references in retrieved articles were reviewed to identify possible further articles that may have been missed in this search. Eligible publications were assessed independently by two reviewers (AV, KB). Studies were included in the meta-analysis if they presented data from a prospective cohort or casecontrol study on the association between adult weight gain and ER-and/or PR-defined breast cancer risk. Studies that did not provide risk estimates (REs) for quantiles of adult weight gain were excluded.
Data extraction and classification
From each publication, we extracted the following information: the name of the first author, the year of publication, the country where the study was conducted, the major ER/PR assay, the name of the cohort study/the type of case-control study, years of follow-up (cohort studies), years of data collection (case-control studies), the number of overall cases, the study size (cohort studies), the number of controls (case-control studies), age, menopausal status, the weight gain categories studied, the effect estimates, and the adjusted factors. Relative risks or odds ratios and 95% confidence intervals (CIs) from regression models were extracted and used for the subsequent analyses. The most fully adjusted REs and CIs for the highest quantile compared to the lowest quantile from each study were used for the meta-analyses. From the REs, the standard error of the estimate (SEE) was directly derived as SEE = [log(95% CI, upper limit) -log(95% CI, lower limit)]/3.92 and was employed in the calculation of the pooled estimates.
Statistical analysis
All analyses were carried out using the ''meta'' and ''rmeta'' packages of the statistical software environment R (version 2.7.1) [22] . The statistical analyses included a test of heterogeneity to determine whether the study results (of groups) were significantly heterogeneous. The correct model for the combination of single study results to a common pooled estimate could thereby be determined. Several statistical and quantifying measurements were used to assess heterogeneity of a set of point estimates together with the respective standard errors, i.e., the s 2 heterogeneity estimator, the Q statistic yielding a (two-sided) p value for heterogeneity, and the I 2 index [23] . Weighting was performed by the inverse variance method [24] based on two commonly used models: the fixed effects model [25] and the random effects model [26] . In the prior model, one assumes that the effects are all in the same direction and of the same magnitude and are thus results of a common pooled effect. In the latter model, by contrast, there is no assumption that the effects are of identical direction and magnitude. Thus, in the random effects model, the study results are combined in a more independent way by allowing variability within and heterogeneity between studies, respectively. Fixed effects models were used when heterogeneity was low (p value [ 0.1). Otherwise, random effects models were used. The individual study results as well as the combined pooled estimates were illustrated in forest plots. We calculated a pooled estimate for prospective cohort studies, case-control studies, and all studies combined. We initially included studies defined by joint ER/PR status and ER status only, and studies in mixed populations (pre-and postmenopausal women combined) and in postmenopausal women. Subsequently, we performed sensitivity analyses including only studies defined by joint ER/PR status or studies restricted to mixed populations or postmenopausal women, separately. For subgroup analyses, differences between the pooled REs were determined by the Q statistic.
In addition, a sensitivity analysis was conducted to investigate publication bias of the included studies. This was visualized using a funnel plot [27, 28] and quantified using weighted linear regression of the effect estimate on its SEE [29] .
Results
Characteristics of studies
We retrieved ten articles on adult weight gain and risk of breast cancer by ER/PR status [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . One article did not provide REs for quantiles of adult weight gain, and was therefore excluded [21] . In total, 9 articles (including 11 studies) on adult weight gain (10 from early adulthood, 1 from age 50 to reference age) and risk of breast cancer by ER/PR status were included in the meta-analysis ( Table 1) . Three of these studies were prospective cohort studies [12] [13] [14] , and eight were population-based case-control studies [15] [16] [17] [18] [19] [20] . Three case-control studies defined breast tumors by ER status only [18, 20] , and nine studies by joint ER/PR status [12] [13] [14] [15] [16] [17] 19] . Four studies were conducted in a mixed population of pre-and postmenopausal women [16, 20] , there were no studies that included only premenopausal women, and seven studies included only postmenopausal women [12] [13] [14] [15] [17] [18] [19] . All studies were conducted in the US, except for one study that was conducted in Sweden [19] . When comparing results for a mixed population of pre-and postmenopausal women combined and for postmenopausal women only, we found statistically significant heterogeneity (p heterogeneity = 0.002) between REs for the mixed population (4 studies; RE = 1.54; 95% CI 0.86, 2.22; p heterogeneity \ 0.0001) and for postmenopausal women only (7 studies; RE = 2.33; 95% CI 2.05, 2.60; p heterogeneity = 0.0024).
ER
-PR -tumors
Fixed effects models were used to assess the association between adult weight gain and ER-negative breast cancer risk. Adult weight gain was associated with an increased risk for ER -PR -and ER -tumors combined (11 studies; RE = 1.36; 95% CI 1.14, 1.58; p heterogeneity = 0.14; Fig. 2 ; Table 2 ).
Results were not statistically significantly heterogeneous (p heterogeneity = 0.92) for the mixed population of pre-and postmenopausal women combined (4 studies; RE = 1.32; 95% CI 0.74, 1.89; p heterogeneity = 0.06) and for postmenopausal women only (7 BMI is the most commonly used anthropometric measure to define obesity, and has been consistently associated with increased postmenopausal breast cancer risk [1] . However, adult weight gain is thought to be a better measure to assess adiposity and its metabolic consequences than BMI. Whereas BMI reflects both lean body mass and adipose mass, weight gain in adult life is generally a gain of body fat and thus potentially represents the age-related metabolic change that may be important in breast cancer development [4] . Several studies examining both adult weight gain and adult BMI in the same study population have found weight gain to be an equivalent [5, 6] or stronger [4, [7] [8] [9] [10] predictor of postmenopausal breast cancer risk than recent BMI.
In postmenopausal women, obesity has been associated with hyperinsulinemia and insulin resistance, and with elevated estradiol and lower SHBG levels [30] . Similar associations have been found for adult weight gain [31] breast cancer and to a lesser extent with increased risk for ER -PR -breast cancer in postmenopausal women, we observed large heterogeneity between the study-specific REs, in particular for ER ? PR ? breast tumors. One possible explanation for this heterogeneity may be differences in the definition of quantiles between studies, which preclude relating risk for ER ? PR ? or ER -PR -breast tumors to specific cut-off measurements of adult weight change. However, the heterogeneity between studies may be due to several other reasons.
Studies were performed in different age groups and adult weight gain has been previously shown to be differentially related to premenopausal and postmenopausal breast cancer risk [11] . Indeed, restricting the studies to those conducted in postmenopausal women reduced heterogeneity. Further, there is a potential for measurement error from self-reported weight and recall of weight during early adulthood. However, correlations between measured and self-reported weight typically are [0.95 [11] , and correlations between recalled weight over several decades and measured weight have been between 0.80 and 0.87 in several studies [32] .
The assay methods for the measurement of ER/PR status and cut-off points for ER/PR status were not available for all studies and also varied across/within studies. This may have led to misclassification of the tumor subtypes and in consequence to attenuation of the observed REs. Some studies only reported on ER and PR status separately whereas other studies considered joint ER/PR status. The combination of ER and PR status is reflective of true tumor estrogen dependence, since tumors will be both ER and PR positive if expression of the PR gene is induced by the presence of a normally functioning ER-estradiol-binding system [33] . Restricting our meta-analyses to studies measuring joint ER/PR status increased the REs.
Current use of hormone replacement therapy increases circulating estrogen levels and may obscure the effect of adult weight gain on postmenopausal breast cancer risk. Some studies restricted their study population of postmenopausal women to non-users of postmenopausal hormones [12] [13] [14] 19] while other studies adjusted for postmenopausal hormone use [15, 17, 18] . However, results for adult weight gain and postmenopausal breast Fig. 1 [14] . It may also be possible that it was more difficult to detect this association in black women due to the smaller study population and the lower proportion of breast carcinomas that are ER ? , PR ? , or both. To account for baseline differences in body size, some studies adjusted the analyses for baseline weight and height or BMI [13, 14, 16, 17] . The other studies either adjusted for recent BMI [18, 19] or did not perform any adjustment for body size [12, 15, 20] . However, results did not appear to differ for studies with and without adjustment. Finally, unknown or residual confounding may be present.
The relation between adult weight gain and ER/PR defined breast cancer risk has not yet been fully clarified. To the best of our knowledge, no studies have been conducted in premenopausal women only. Future studies should investigate whether adult weight gain has a differential effect on ER ? PR ? premenopausal breast cancer risk, as is suggested by the lower REs in the mixed population of pre-and postmenopausal women combined compared to those in postmenopausal women.
Further, it is unclear whether adult weight gain throughout the entire adulthood lifespan or weight gain during specific life stages is most relevant for the observed increase in ER ? PR ? -defined postmenopausal breast cancer risk. Weight gain during pubertal years is distributed primarily on the hips and buttocks. During later adult life, fat accumulates preferentially around the waist. Only few studies have addressed the effect of adult weight gain during multiple life stages with respect to overall postmenopausal breast cancer risk. Three prospective cohort studies and one case-control study showed that both adult weight gain before and after menopause were associated with postmenopausal breast cancer risk [13, 18, 34, 35] whereas in one case-control study an increase in risk was only evident for adult weight gain after menopause [17] . None of these studies investigated whether these associations differed by ER/PR status of the tumor.
In conclusion, the association between adult weight gain and postmenopausal breast cancer risk is heterogeneous according to ER/PR status of the tumor, with higher REs for ER ?
PR
? than for ER -
-tumors. The association of adult weight gain with ER/PR-defined premenopausal breast cancer risk could not be independently assessed. These findings suggest that control of body weight may prevent ER ?
? tumors, and to a lesser extent ER -
-tumors, after menopause. 
